Ketorolac
Generic Name: ketorolac (KEE-toe-ROLE-ak)
Brand Name: Toradol
Brand Name: Toradol
Ketorolac is only intended for short-term (up to 5 days) treatment of moderately severe pain. It should not be used to treat minor or long-term pain. Do not use more of ketorolac than prescribed. Do not use ketorolac to treat children.
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID). It may cause an increased risk of serious and sometimes fatal heart and blood vessel problems (eg, heart attack, stroke). The risk may be greater if you already have heart problems or if you take ketorolac for a long time. Do not use ketorolac right before or after coronary artery bypass graft (CABG).
Ketorolac may cause an increased risk of serious and sometimes fatal stomach ulcers and bleeding. Elderly patients may be at greater risk. This may occur without warning signs.
Do not use ketorolac if:
- you are allergic to ketorolac, aspirin, or any other NSAIDs (eg, ibuprofen, celecoxib)
- you are taking aspirin or another NSAID (eg, ibuprofen, celecoxib)
- you are breast-feeding or are in labor
- you have recently had or will be having CABG
- you have a stomach ulcer or a history of ulcers or severe stomach problems (eg, bleeding, perforation)
- you have severe kidney problems or are at risk of kidney failure (eg, low blood volume, dehydrated)
- you have bleeding in the brain (eg, stroke, aneurysm) or bleeding problems (eg, platelet disorder, hemophilia), or you are at risk of bleeding
Do not use ketorolac to prevent pain before any major surgery.
Ketorolac is used for:
The short-term (up to 5 days) treatment of moderately severe pain (usually after surgery), alone or in combination with other medicines.
Ketorolac is an NSAID. Exactly how it works is not known. It may block certain substances in the body that are linked to inflammation. NSAIDs treat the symptoms of pain and inflammation. They do not treat the disease that causes these symptoms.
Do NOT use ketorolac if:
- you are allergic to any ingredient in ketorolac
- you have had a severe allergic reaction (eg, severe rash, hives, breathing difficulties, dizziness) to aspirin or an NSAID (eg, ibuprofen, naproxen, celecoxib)
- you are taking pentoxifylline, probenecid, aspirin, or another NSAID (eg, ibuprofen, celecoxib)
- you are in the last 3 months of pregnancy, are breast-feeding, or are in labor
- you have recently had or will be having CABG or you have a stomach ulcer or a history of ulcers or severe stomach problems (eg, bleeding, perforation)
- you have severe kidney problems or are at risk of kidney failure (eg, low blood volume, dehydrated)
- you have bleeding in the brain (eg, stroke, aneurysm) or bleeding problems (eg, platelet disorder, hemophilia), or you are at risk of bleeding
- you need to prevent pain before any major surgery
Contact your doctor or health care provider right away if any of these apply to you.
Before using ketorolac:
Some medical conditions may interact with ketorolac. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
- if you are pregnant, planning to become pregnant, or are breast-feeding
- if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
- if you have allergies to medicines, foods, or other substances
- if you have a history of kidney or liver problems, diabetes, or stomach or bowel problems (eg, bleeding, perforation, ulcers, Crohn disease)
- if you have a history of swelling or fluid buildup, asthma, growths in the nose (nasal polyps), or mouth inflammation
- if you have high blood pressure, blood disorders (eg, porphyria), bleeding or clotting problems, heart problems (eg, heart failure), or blood vessel disease, or you are at risk of any of these diseases
- if you have poor health, dehydration or low fluid volume, or low blood sodium levels, you smoke, drink alcohol, or have a history of alcohol abuse
Some MEDICINES MAY INTERACT with ketorolac. Tell your health care provider if you are taking any other medicines, especially any of the following:
- Anticoagulants (eg, warfarin), aspirin, clopidogrel, corticosteroids (eg, prednisone), heparin and other blood thinners (eg, dalteparin), pentoxifylline, or selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) because the risk of bleeding may be increased
- Probenecid because it may increase the risk of ketorolac's side effects
- Cyclosporine, lithium, metformin, methotrexate, oral NSAIDs (eg, ibuprofen), or quinolones (eg, ciprofloxacin) because the risk of their side effects may be increased by ketorolac
- Angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril) or diuretics (eg, furosemide, hydrochlorothiazide) because their effectiveness may be decreased by ketorolac
This may not be a complete list of all interactions that may occur. Ask your health care provider if ketorolac may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Brand Name | Contains | Dosage Form | Manufacturer | Price(Tk.) |
ACUPAIN | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Beacon Pharmaceuticals Ltd. | 30s pack: 300.00 MRP |
ACUPAIN | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Beacon Pharmaceuticals Ltd. | 30mg (1ml) amp x 5s pack: 275.00 MRP |
ANALAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Ziska Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
ANALAC | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Ziska Pharmaceuticals Ltd. | 30mg (1ml) amp x 5s pack: 275.00 MRP |
AROLAK | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Ambee Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
AROLAK | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule | i.m/i.v Injection | Ambee Pharmaceuticals Ltd. | 10mg (1ml) amp x 5s pack: 150.00 MRP; 30mg (1ml) amp x 5s pack: 275.00 MRP |
E-KET | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Edruc Limited | 20s pack: 200.00 IP |
E-KET | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Edruc Limited | 30mg (1ml) amp x 5s pack: 250.00 MRP |
EMODOL | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Jayson Pharmaceuticals Ltd. | 20s pack: 200.00 IP |
EMODOL | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule | i.m/i.v Injection | Jayson Pharmaceuticals Ltd. | 10mg (1ml) amp x 10s pack: 331.30 IP; 30mg (1ml) amp x 5s pack: 250.00 IP; 30mg (1ml) amp x 10s pack: 556.30 IP |
ETOLAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Ibn Sina Pharmaceutical Ind. Ltd. | 20s pack: 200.00 MRP |
ETOLAC | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule & 60mg/2ml ampoule | i.m/i.v Injection | Ibn Sina Pharmaceutical Ind. Ltd. | 10mg (1ml) amp x 10s pack: 320.00 MRP; 30mg (1ml) amp x 10s pack: 550.00 MRP; 60mg (2ml) amp x 1s pack: 95.00 MRP |
ETORAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Incepta Pharmaceuticals Ltd. | 30s pack: 300.00 MRP |
ETORAC | Ketorolac tromethamine 30mg/1ml ampoule & 60mg/1ml ampoule | i.m/i.v Injection | Incepta Pharmaceuticals Ltd. | 30mg (1ml) amp x 1s pack: 55.00 MRP; 60mg (2ml) amp x 1s pack: 95.00 MRP |
KELAC | Ketorolac tromethamine 10mg/tablet | Tablet | Chemist Laboratories Ltd. | 20s pack: 160.00 MRP |
KELAC | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule | i.m/i.v Injection | Chemist Laboratories Ltd. | 10mg (1ml) amp x 5s pack: 125.00 MRP; 30mg (1ml) amp x 5s pack: 175.00 MRP |
KENODOL | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Rangs Pharmaceuticals Ltd. | 20s pack: 240.00 MRP |
KENODOL | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Rangs Pharmaceuticals Ltd. | 30mg (1ml) amp x 6s pack: 300.00 MRP |
KEROLAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Gaco Pharmaceuticals | 20s pack: 200.00 MRP |
KETEKS | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | RAK Pharmaceuticals Pvt. Ltd. | 30s pack: 300.00 MRP |
Brand Name | Contains | Dosage Form | Manufacturer | Price(Tk.) |
KETOBE 10 | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Benham Pharmaceutical Ltd. | 30s pack: 298.20 MRP |
KETOFLEX | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Somatec Pharmaceutical Ltd. | 20s pack: 200.00 MRP |
KETONIC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Eskayef Bangladesh Ltd. | 20s pack: 200.00 MRP |
KETONIC | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule | i.m/i.v Injection | Eskayef Bangladesh Ltd. | 10mg (1ml) amp x 5s pack: 160.00 MRP; 30mg (1ml) amp x 5s pack: 275.00 MRP |
KETORIN | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Orion Pharma Ltd. | 20s pack: 200.00 MRP |
KETORIN | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Orion Pharma Ltd. | 30mg (1ml) amp x 5s pack: 250.00 MRP |
KETROMIN | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Pacific Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
KFLAM | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Apex Pharmaceuticals Ltd. | 20s pack: 120.00 MRP |
KFLAM | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Apex Pharmaceuticals Ltd. | 30mg (1ml) amp x 5s pack: 200.00 MRP |
LOPADOL | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Popular Pharmaceuticals Ltd. | 20s pack: 200.00 IP |
LOPADOL | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Popular Pharmaceuticals Ltd. | 30mg (1ml) amp x 5s pack: 250.00 IP |
MINOLAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | ACI Ltd. | 20s pack: 200.00 IP |
MINOLAC | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | ACI Ltd. | 30mg (1ml) amp x 1s pack: 55.00 IP |
OFPAIN | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Kemiko Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
OFPAIN | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Kemiko Pharmaceuticals Ltd. | 30mg (1ml) amp x 1s pack: 50.00 MRP |
ORADOL | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Aristopharma Ltd. | 20s pack: 200.00 MRP |
ORADOL | Ketorolac tromethamine 30mg/1ml ampoule & 60mg/1ml ampoule | i.m/i.v Injection | Aristopharma Ltd. | 30mg (1ml) amp x 1s pack: 55.00 MRP; 60mg (2ml) amp x 1s pack: 95.00 MRP |
ORC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Navana Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
PAIR | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Drug International Ltd. | 30s pack: 300.00 MRP |
PAIR -30 | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Drug International Ltd. | 30mg (1ml) amp x 5s pack: 250.00 MRP |
PERILAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Bio Pharma Laboratories Ltd. | 20s pack: 200.00 MRP |
PERILAC | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule | i.m/i.v Injection | Bio Pharma Laboratories Ltd. | 10mg (1ml) amp x 5s pack: 150.00 MRP; 30mg (1ml) amp x 5s pack: 250.00 MRP |
ROKET 10 | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Globe Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
ROKET 30 | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Globe Pharmaceuticals Ltd. | 30mg (1ml) amp x 5s pack: 250.00 MRP |
ROLAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Renata Limited | 30s pack: 300.00 MRP |
ROLAC | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule & 60mg/2ml ampoule | i.m/i.v Injection | Renata Limited | 10mg (1ml) amp x 1s pack: 32.00 MRP; 30mg (1ml) amp x 1s pack: 55.00 MRP; 60mg (2ml) amp x 2s pack: 190.00 MRP |
ROTEK | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Health Care Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
ROTEK | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Health Care Pharmaceuticals Ltd. | 30mg (1ml) amp x 5s pack: 250.00 MRP |
TODOL | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Opsonin Pharma Limited | 30s pack: 300.00 MRP |
TODOL | Ketorolac tromethamine 30mg/1ml ampoule & 60mg/1ml ampoule | i.m/i.v Injection | Opsonin Pharma Limited | 30mg (1ml) amp x 5s pack: 280.00 MRP; 60mg (2ml) amp x 1s pack: 95.00 MRP |
TOLEC | Ketorolac tromethamine USP 10mg/tablet | Tablet (film-coated) | Alco Pharma Ltd. | 20s pack: 200.00 MRP |
TORADOL | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Roche Bangladesh Pharmaceuticals Ltd. | 20s pack: 460.20 MRP |
TORAX | Ketorolac tromethamine 10mg/1ml ampoule & 30mg/1ml ampoule & 60mg/2ml ampoule | i.m/i.v Injection | Square Pharmaceuticals Ltd. | 10mg (1ml) amp x 5s pack: 150.00 MRP; 30mg (1ml) amp x 5s pack: 275.00 MRP; 60mg (2ml) amp x 1s pack: 95.00 MRP |
TORAX 10 | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Square Pharmaceuticals Ltd. | 30s pack: 300.00 MRP |
TOROLAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Silva Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
WINOP | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Acme Laboratories Ltd. | 20s pack: 200.00 MRP |
WINOP | Ketorolac tromethamine 30mg/1ml ampoule & 60mg/1ml ampoule | i.m/i.v Injection | Acme Laboratories Ltd. | 10mg (1ml) amp x 5s pack: 150.00 MRP; 30mg (1ml) amp x 1s pack: 50.00 MRP |
XENOLAC-10 | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Shamsul Alamin Pharmaceuticals Ltd. | 20s pack: 200.00 MRP |
XIDOLOC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Beximco Pharmaceuticals Ltd. | 20s pack: 200.00 IP |
ZEPAC | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Novartis (Bangladesh) Ltd. | 30s pack: 300.00 MRP |
ZEPAC | Ketorolac tromethamine 30mg/1ml ampoule | i.m/i.v Injection | Novartis (Bangladesh) Ltd. | 30mg (1ml) amp x 5s pack: 300.00 MRP |
ZEROPAIN | Ketorolac tromethamine 10mg/tablet | Tablet (film-coated) | Health Care Pharmaceuticals Ltd. | 20s pack: 240.00 MRP |
For the Consumer
Applies to ketorolac: injectable, solution, tablet
Other dosage forms:
In addition to its needed effects, some unwanted effects may be caused by ketorolac. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking ketorolac:
More common
- Swelling of face, fingers, lower legs, ankles, and/or feet
- weight gain (unusual)
Less common
- Bruising (not at place of injection)
- high blood pressure
- skin rash or itching
- small, red spots on skin
- sores, ulcers, or white spots on lips or in mouth
Rare
- Abdominal or stomach pain, cramping, or burning that is severe
- bleeding from the rectum or bloody or black, tarry stools
- bloody or cloudy urine
- blue lips and fingernails
- blurred vision of other vision change
- burning, red, tender, thick, scaly, or peeling skin
- chest pain
- convulsions
- cough or hoarseness
- dark urine
- decrease in amount of urine that is sudden
- fainting
- fast, irregular, noisy, or troubled breathing
- fever with severe headache, drowsiness, confusion, and stiff neck or back
- fever with or without chills or sore throat
- hallucinations (seeing, hearing, or feeling things that are not there)
- hearing loss
- hives
- increase in amount of urine or urinating often
- light-colored stools
- loss of appetite
- low blood pressure
- mood changes or unusual behavior
- muscle cramps or pain
- nausea, heartburn, or indigestion that is severe and continues
- nosebleeds
- pain in lower back and/or side
- pain, tenderness, or swelling in the upper stomach area
- painful or difficult urination
- pale skin
- puffiness or swelling of the eyelids or eyes
- ringing or buzzing in ears
- runny nose
- severe restlessness
- shortness of breath
- swollen or painful glands
- swollen tongue
- thirst that continues
- tightness in the chest with or without wheezing
- unusual tiredness or weakness
- vomiting of blood or material that looks like coffee grounds
- yellow eyes or skin
Some of the side effects that can occur with ketorolac may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:
More common
- Abdominal or stomach pain (mild or moderate)
- bruising at place of injection
- diarrhea
- dizziness
- drowsiness
- headache
- indigestion
- nausea
Less common or rare
- Bloating or gas
- burning or pain at place of injection
- constipation
- feeling of fullness in abdominal or stomach area
- increased sweating
- vomiting
For Healthcare Professionals
Applies to ketorolac: injectable solution, nasal spray, oral tablet
Renal
Acute renal failure has been reported with short-term use of ketorolac, even with moderate doses. Hyperkalemia often accompanies acute renal failure. Chronic ketorolac exposure may result in transient increases in BUN and creatinine in 2% to 3% of patients. Renal papillary necrosis has also been reported after chronic ketorolac exposure in some animal studies.
Patients with preexisting renal disease, congestive heart failure, hypovolemia, hepatic cirrhosis, nephrotic syndrome, or hypoalbuminemia are at increased risk for acute renal failure during ketorolac therapy as renal function in these conditions is dependent upon renal prostaglandin synthesis. Risk versus benefit should be carefully weighed in such patients.
In addition, ketorolac may have renal-metabolic effects such as salt and water retention, inhibition of diuretic action, and hyperkalemia due to suppression of the renin-angiotensin-aldosterone system. These effects are similar to those reported with other nonsteroidal anti-inflammatory agents.
Renal failure associated with hemolytic uremic syndrome developed in a 58-year-old female treated for arthralgias with oral ketorolac. After a total dose of 30 mg the patient developed vomiting and bloody diarrhea. Three days later, the patient again developed nausea, vomiting, oliguria, facial and peripheral edema, and hypertension. Hemolytic anemia, thrombocytopenia, elevated lactate dehydrogenase, decreased fibrinogen, and renal failure were noted on laboratory evaluation. Treatment consisted of furosemide and supportive care. Eight days later, all laboratory values were within normal limits and the patient was well.
A case-control study suggested that patients who consumed 5000 or more pills containing NSAIDs during their lifetime may be at increased risk of end-stage renal disease.
Patients with preexisting renal disease, congestive heart failure, hypovolemia, hepatic cirrhosis, nephrotic syndrome, or hypoalbuminemia are at increased risk for acute renal failure during ketorolac therapy as renal function in these conditions is dependent upon renal prostaglandin synthesis. Risk versus benefit should be carefully weighed in such patients.
In addition, ketorolac may have renal-metabolic effects such as salt and water retention, inhibition of diuretic action, and hyperkalemia due to suppression of the renin-angiotensin-aldosterone system. These effects are similar to those reported with other nonsteroidal anti-inflammatory agents.
Renal failure associated with hemolytic uremic syndrome developed in a 58-year-old female treated for arthralgias with oral ketorolac. After a total dose of 30 mg the patient developed vomiting and bloody diarrhea. Three days later, the patient again developed nausea, vomiting, oliguria, facial and peripheral edema, and hypertension. Hemolytic anemia, thrombocytopenia, elevated lactate dehydrogenase, decreased fibrinogen, and renal failure were noted on laboratory evaluation. Treatment consisted of furosemide and supportive care. Eight days later, all laboratory values were within normal limits and the patient was well.
A case-control study suggested that patients who consumed 5000 or more pills containing NSAIDs during their lifetime may be at increased risk of end-stage renal disease.
Renal side effects have included acute renal failure and flank pain. Oliguria, nephritis, hyperkalemia, hematuria, proteinuria, and urinary frequency have also been reported. Ketorolac has also been implicated in a case of hemolytic uremic syndrome.
Gastrointestinal
As with other nonsteroidal anti-inflammatory agents, gastrointestinal complaints are common in patients on ketorolac therapy. While these effects are usually mild in nature, serious gastrointestinal effects are reported, including peptic and colonic ulceration and gastrointestinal bleeding and perforation. Serious gastrointestinal bleeding may not be preceded by symptoms. While experience is limited, there is some indication that the risk of serious gastrointestinal effects increases with prolonged treatment with ketorolac. Thus, ketorolac is only recommended for the short-term management of pain.
Patients with a history of serious gastrointestinal events or alcohol abuse are at increased risk for severe gastrointestinal side effects. Ketorolac should be used with caution in these patients.
Patients with a history of serious gastrointestinal events or alcohol abuse are at increased risk for severe gastrointestinal side effects. Ketorolac should be used with caution in these patients.
Gastrointestinal side effects have included gastrointestinal pain (13%), nausea (12%), dyspepsia (12%), diarrhea, constipation, flatulence, stomatitis, rectal bleeding, and melena. More serious effects include peptic ulceration (including giant gastric and duodenal ulcers), and gastrointestinal bleeding and perforation. GI bleeding increased with larger doses, therapy duration longer than 5 days, and older patients. Pancreatitis and exacerbation of inflammatory bowel disease (ulcerative colitis, Crohn's disease) has also been reported.
Hematologic
Hematologic side effects have included purpura, thrombocytopenia, epistaxis, inhibition of platelet aggregation, increased bleeding time, leukopenia, and eosinophilia.
Hepatic
Hepatic side effects have included borderline increases in liver function tests in up to 15% of patients in clinical trials. However, significant increases (three times normal values) occur in less than 1% of patients. Hepatitis, liver failure, and cholestatic jaundice have been reported during postmarketing experience.
Respiratory
Respiratory side effects have included dyspnea, asthma, wheezing, and pulmonary edema.
Nervous system
Nervous system side effects have included headache (17%), somnolence or drowsiness (3% to 9%), dizziness (3% to 9%), convulsions, vertigo, tremors, hallucinations, and euphoria. In addition, paresthesias, stupor, and hyperkinesia are reported; causality is unknown.
Cardiovascular
Nonsteroidal anti-inflammatory drugs (NSAIDs) may elevate blood pressure and increase the risk for the initiation of antihypertensive therapy. Furthermore, NSAIDs may antagonize the blood pressure lowering effect of antihypertensive medications in patients already being treated with antihypertensive drugs.
Cardiovascular side effects have included edema, palpitations, vasodilation, hypotension, syncope, and pallor. In addition, blood pressure may be elevated by ketorolac which may have clinical relevance in patients with comorbid illnesses.
Dermatologic
Dermatologic side effects have included rash, pruritus, and urticaria. Exfoliative dermatitis has also been reported.
Hypersensitivity
Hypersensitivity side effects have included anaphylaxis, bronchospasm, acute angioedema (including laryngeal and tongue edema), and fever. Lyell's syndrome, erythema multiforme, bullous reactions such Stevens-Johnson syndrome, and toxic epidermal necrolysis have also been reported.
Local
Local side effects associated with intramuscular injection of ketorolac include local pain, ecchymosis, bruising, hematoma, and tingling.
Ocular
Ocular side effects have included altered or blurred vision in less than 1% of patients.
Psychiatric
Psychiatric side effects have included depression, insomnia, abnormal dreams, and nervousness.
Other
Other side effects have included rare reports of tinnitus and hearing loss. Weight gain during long-term ketorolac therapy has also been reported.
0 comments:
Post a Comment